Search Results for "Bacterial"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Bacterial. Results 191 to 200 of 344 total matches.

Prevention and Treatment of Pertussis

   
The Medical Letter on Drugs and Therapeutics • Sep 17, 2012  (Issue 1399)
and erythromycin are alternatives. For patients who cannot take macrolide antibiotics, trimethoprim ...
The CDC has reported that many states are experiencing a higher-than-usual incidence of pertussis this year. The highest incidence has been in infants, but the disease has also occurred in older children, adolescents, and adults. Thirteen pertussis-related deaths were reported through August 24; the majority of these were in infants <3 months old.
Med Lett Drugs Ther. 2012 Sep 17;54(1399):73-4 |  Show IntroductionHide Introduction

Omidubicel (Omisirge) for Neutrophil Recovery Following Myeloablative Conditioning Therapy (online only)

   
The Medical Letter on Drugs and Therapeutics • May 29, 2023  (Issue 1677)
transplantation. Grade 2/3 bacterial or grade 3 invasive fungal infections up to 100 days post-transplantation ...
The FDA has approved omidubicel-onlv (Omisirge – Gamida Cell), a nicotinamide-modified, allogeneic hematopoietic progenitor cell therapy derived from cord blood, to reduce the time to neutrophil recovery and the risk of infection in patients ≥12 years old with hematologic malignancies who will undergo umbilical cord blood transplantation following myeloablative conditioning therapy. Hematopoietic progenitor cell (HPC) umbilical cord products (e.g., Allocord, Clevecord, Ducord) have been available in the US for years for the same indication. Cord blood banks also supply cord...
Med Lett Drugs Ther. 2023 May 29;65(1677):e93-4   doi:10.58347/tml.2023.1677h |  Show IntroductionHide Introduction

In Brief: New Warning for the RSV Vaccines Arexvy and Abrysvo

   
The Medical Letter on Drugs and Therapeutics • Feb 17, 2025  (Issue 1722)
or bacterial infection. Administration of some COVID-19 and seasonal influenza vaccines has been associated ...
The FDA has required a new warning in the labels of the recombinant respiratory syncytial virus (RSV) vaccines Arexvy (GSK) and Abrysvo (Pfizer) about an increased risk of Guillain-Barré syndrome (GBS) within 42 days of administration of either vaccine. Both vaccines are FDA-approved to prevent lower respiratory tract disease (LRTD) caused by RSV in adults.Abrysvo is also approved for use in pregnant women at 32-36 weeks' gestation to prevent RSV-associated LRTD in their infants from birth through 6 months of age.
Med Lett Drugs Ther. 2025 Feb 17;67(1722):31-2   doi:10.58347/tml.2025.1722d |  Show IntroductionHide Introduction

Drug Interactions

   
The Medical Letter on Drugs and Therapeutics • Jun 08, 2003  (Issue 1158)
, progesterone, testosterone Macrolide antibiotics: clarithromycin (Biaxin), erythromycin (Erythrocin ...
Changes caused by one drug in the absorption, distribution, metabolism or excretion of another may lead to a pharmacokinetic adverse drug interaction (DN Juurlink et al, JAMA 2003; 289:1652). Additive drug interactions, such as vasodilation caused by both sildenafil (Viagra) and nitrates, can also have adverse effects.
Med Lett Drugs Ther. 2003 Jun 8;45(1158):46-8 |  Show IntroductionHide Introduction

Proton Pump Inhibitors for GERD in Children

   
The Medical Letter on Drugs and Therapeutics • Feb 26, 2007  (Issue 1255)
-receptor antagonist may result in bacterial overgrowth, and in one study was associated with an increased ...
A recent advertisement for the proton pump inhibitor (PPI) lansoprazole (Prevacid - TAP) suggests that children who cough at night, complain of abdominal pain, refuse to eat, or have a bad taste in their mouths may all have gastroesophageal reflux disease (GERD). A Bunny's Tummy Trouble, a children's book about GERD published by TAP, is now available as a patient handout in pediatricians' waiting rooms. The use of acid-suppressive drugs in infants and children has increased markedly in recent years and many of these drugs are now available in child-friendly formulations. A table in the article...
Med Lett Drugs Ther. 2007 Feb 26;49(1255):17-8 |  Show IntroductionHide Introduction

Drugs for Pneumonia

   
Treatment Guidelines from The Medical Letter • Sep 01, 2003  (Issue 13)
) and is implicated by other microbiologic techniques in at least another 20%. Other bacterial pathogens ...
The choice of drugs for treatment of pneumonia depends on the most likely pathogens causing the infection and local antimicrobial resistance patterns. Factors such as severity of illness, presence of co-morbid conditions and whether the infection is community or hospital-acquired also need to be considered.
Treat Guidel Med Lett. 2003 Sep;1(13):83-8 |  Show IntroductionHide Introduction

Gallium For Hypercalcemia of Malignancy

   
The Medical Letter on Drugs and Therapeutics • May 03, 1991  (Issue 843)
, such as aminoglycoside antibiotics, is contraindicated. Hypocalcemia and hypophosphatemia occur frequently ...
Gallium nitrate (Ganite - Fujisawa, USA), originally an anticancer drug, was recently marketed for treatment of cancer-associated hypercalcemia that has not responded to hydration. Other drugs used for treatment of hypercalcemia include furosemide (Lasix, and others), the bisphosphonate etidronate (Didronel IV), calcitonin (Calcimar), and plicamycin (Mithracin, formerly mithramycin) (RAB Schaiff et al, Clin Pharm, 8:108, 1989). Newer bisphosphonates are available in Europe.
Med Lett Drugs Ther. 1991 May 3;33(843):41-2 |  Show IntroductionHide Introduction

Flosequinan for Heart Failure

   
The Medical Letter on Drugs and Therapeutics • Mar 19, 1993  (Issue 892)
:116, Jan 9, 1993). INTERACTIONS — Fluoroquinolone antibiotics interact with many other drugs ...
Flosequinan (Manoplax - Boots), a fluoroquinolone derivative, is now available in the USA for treatment of congestive heart failure. Labeling approved by the US Food and Drug Administration recommends the drug only for patients who cannot tolerate or have not responded adequately to an angiotensin-converting enzyme (ACE) inhibitor.
Med Lett Drugs Ther. 1993 Mar 19;35(892):23-4 |  Show IntroductionHide Introduction

Peripheral-Blood Stem-Cells Transplants

   
The Medical Letter on Drugs and Therapeutics • Aug 18, 1995  (Issue 955)
duration of hospitalization and less need for blood products, antibiotics and other supportive care (TJ ...
High-dose chemotherapy, with or without total body radiation, followed by bone marrow transplantation to restore bone marrow function has been used widely in the treatment of malignant diseases in recent years (Medical Letter, 34:79, 1992; 37:25, 1995). Now, however, instead of using bone marrow itself to restore function destroyed by chemotherapy and radiation, many centers infuse hematopoietic stem cells harvested from peripheral blood. Most stem cell transplants have been autologous; allogeneic stem cells have been tried in a small number of patients (WI Bensinger et al, Blood,...
Med Lett Drugs Ther. 1995 Aug 18;37(955):71-2 |  Show IntroductionHide Introduction

Adapalene for Acne

   
The Medical Letter on Drugs and Therapeutics • Feb 28, 1997  (Issue 995)
FOR ACNE Drug Formulation 1 Cost 2 Adapalene Differin (Galderma) 0.1% gel 15 gm − $22.08 Antibiotics ...
Adapalene (Differin - Galderma), a synthetic retinoid analog, has been marketed in the USA in a 0.1% gel formulation for topical treatment of acne vulgaris.
Med Lett Drugs Ther. 1997 Feb 28;39(995):19-20 |  Show IntroductionHide Introduction